vs
Lifeway Foods, Inc.（LWAY）与自然阳光（NATR）财务数据对比。点击上方公司名可切换其他公司
自然阳光的季度营收约是Lifeway Foods, Inc.的2.2倍（$123.8M vs $55.4M）。Lifeway Foods, Inc.净利率更高（4.6% vs 3.3%，领先1.3%）。Lifeway Foods, Inc.同比增速更快（18.0% vs 4.7%）。自然阳光自由现金流更多（$7.6M vs $-17.4M）。过去两年Lifeway Foods, Inc.的营收复合增速更高（11.4% vs 5.6%）
来福威食品公司是一家总部位于美国伊利诺伊州的健康食品企业，成立于1986年，是美国业内领先的开菲尔发酵益生菌产品供应商，这类产品主要用于调节人体微生物群平衡。
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
LWAY vs NATR — 直观对比
营收规模更大
NATR
是对方的2.2倍
$55.4M
营收增速更快
LWAY
高出13.2%
4.7%
净利率更高
LWAY
高出1.3%
3.3%
自由现金流更多
NATR
多$25.0M
$-17.4M
两年增速更快
LWAY
近两年复合增速
5.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $55.4M | $123.8M |
| 净利润 | $2.5M | $4.1M |
| 毛利率 | 27.8% | 72.5% |
| 营业利润率 | 6.8% | 4.3% |
| 净利率 | 4.6% | 3.3% |
| 营收同比 | 18.0% | 4.7% |
| 净利润同比 | 1688.1% | 1379.4% |
| 每股收益（稀释后） | $0.15 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LWAYNATR
| Q4 25 | $55.4M | $123.8M | ||
| Q3 25 | $57.1M | $128.3M | ||
| Q2 25 | $53.9M | $114.8M | ||
| Q1 25 | $46.1M | $113.2M | ||
| Q4 24 | $46.9M | $118.2M | ||
| Q3 24 | $46.1M | $114.6M | ||
| Q2 24 | $49.2M | $110.6M | ||
| Q1 24 | $44.6M | $111.0M |
净利润LWAYNATR
| Q4 25 | $2.5M | $4.1M | ||
| Q3 25 | $3.5M | $5.3M | ||
| Q2 25 | $4.2M | $5.3M | ||
| Q1 25 | $3.5M | $4.7M | ||
| Q4 24 | $-160.0K | $-321.0K | ||
| Q3 24 | $3.0M | $4.3M | ||
| Q2 24 | $3.8M | $1.3M | ||
| Q1 24 | $2.4M | $2.3M |
毛利率LWAYNATR
| Q4 25 | 27.8% | 72.5% | ||
| Q3 25 | 28.7% | 73.3% | ||
| Q2 25 | 28.6% | 71.7% | ||
| Q1 25 | 23.9% | 72.1% | ||
| Q4 24 | 25.3% | 72.0% | ||
| Q3 24 | 25.7% | 71.3% | ||
| Q2 24 | 27.0% | 71.4% | ||
| Q1 24 | 25.8% | 71.2% |
营业利润率LWAYNATR
| Q4 25 | 6.8% | 4.3% | ||
| Q3 25 | 8.8% | 7.0% | ||
| Q2 25 | 10.8% | 3.7% | ||
| Q1 25 | 3.4% | 5.4% | ||
| Q4 24 | 1.5% | 3.8% | ||
| Q3 24 | 9.1% | 4.6% | ||
| Q2 24 | 11.0% | 5.1% | ||
| Q1 24 | 8.0% | 4.2% |
净利率LWAYNATR
| Q4 25 | 4.6% | 3.3% | ||
| Q3 25 | 6.2% | 4.2% | ||
| Q2 25 | 7.9% | 4.6% | ||
| Q1 25 | 7.7% | 4.2% | ||
| Q4 24 | -0.3% | -0.3% | ||
| Q3 24 | 6.5% | 3.8% | ||
| Q2 24 | 7.7% | 1.2% | ||
| Q1 24 | 5.4% | 2.1% |
每股收益（稀释后）LWAYNATR
| Q4 25 | $0.15 | $0.23 | ||
| Q3 25 | $0.23 | $0.30 | ||
| Q2 25 | $0.28 | $0.28 | ||
| Q1 25 | $0.23 | $0.25 | ||
| Q4 24 | $0.00 | $-0.02 | ||
| Q3 24 | $0.19 | $0.23 | ||
| Q2 24 | $0.25 | $0.07 | ||
| Q1 24 | $0.16 | $0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.6M | $93.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $85.8M | $161.6M |
| 总资产 | $105.6M | $261.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LWAYNATR
| Q4 25 | $5.6M | $93.9M | ||
| Q3 25 | $23.0M | $95.6M | ||
| Q2 25 | $21.2M | $81.3M | ||
| Q1 25 | $19.4M | $86.5M | ||
| Q4 24 | $16.7M | $84.7M | ||
| Q3 24 | $20.6M | $78.7M | ||
| Q2 24 | $14.6M | $68.7M | ||
| Q1 24 | $12.0M | $77.8M |
总债务LWAYNATR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.5M | $2.1M |
股东权益LWAYNATR
| Q4 25 | $85.8M | $161.6M | ||
| Q3 25 | $82.8M | $166.7M | ||
| Q2 25 | $78.7M | $163.7M | ||
| Q1 25 | $74.2M | $167.1M | ||
| Q4 24 | $71.9M | $161.0M | ||
| Q3 24 | $71.5M | $162.6M | ||
| Q2 24 | $68.0M | $156.4M | ||
| Q1 24 | $63.5M | $159.7M |
总资产LWAYNATR
| Q4 25 | $105.6M | $261.1M | ||
| Q3 25 | $109.5M | $264.8M | ||
| Q2 25 | $98.3M | $254.9M | ||
| Q1 25 | $93.7M | $252.7M | ||
| Q4 24 | $90.5M | $240.9M | ||
| Q3 24 | $91.3M | $245.3M | ||
| Q2 24 | $84.9M | $235.8M | ||
| Q1 24 | $82.8M | $247.3M |
负债/权益比LWAYNATR
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.04× | 0.01× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $267.0K | $9.9M |
| 自由现金流经营现金流 - 资本支出 | $-17.4M | $7.6M |
| 自由现金流率自由现金流/营收 | -31.5% | 6.1% |
| 资本支出强度资本支出/营收 | 31.9% | 1.9% |
| 现金转化率经营现金流/净利润 | 0.11× | 2.41× |
| 过去12个月自由现金流最近4个季度 | $-16.4M | $28.8M |
8季度趋势，按日历期对齐
经营现金流LWAYNATR
| Q4 25 | $267.0K | $9.9M | ||
| Q3 25 | $6.9M | $18.5M | ||
| Q2 25 | $3.9M | $4.3M | ||
| Q1 25 | $-150.0K | $2.6M | ||
| Q4 24 | $-2.6M | $12.2M | ||
| Q3 24 | $7.5M | $9.6M | ||
| Q2 24 | $6.5M | $1.3M | ||
| Q1 24 | $1.5M | $2.2M |
自由现金流LWAYNATR
| Q4 25 | $-17.4M | $7.6M | ||
| Q3 25 | $1.8M | $16.8M | ||
| Q2 25 | $1.6M | $3.0M | ||
| Q1 25 | $-2.4M | $1.5M | ||
| Q4 24 | $-3.8M | $10.0M | ||
| Q3 24 | $5.9M | $7.9M | ||
| Q2 24 | $5.1M | $-2.0M | ||
| Q1 24 | $-923.0K | $-1.5M |
自由现金流率LWAYNATR
| Q4 25 | -31.5% | 6.1% | ||
| Q3 25 | 3.1% | 13.1% | ||
| Q2 25 | 3.0% | 2.6% | ||
| Q1 25 | -5.1% | 1.3% | ||
| Q4 24 | -8.2% | 8.5% | ||
| Q3 24 | 12.8% | 6.9% | ||
| Q2 24 | 10.4% | -1.9% | ||
| Q1 24 | -2.1% | -1.4% |
资本支出强度LWAYNATR
| Q4 25 | 31.9% | 1.9% | ||
| Q3 25 | 9.0% | 1.3% | ||
| Q2 25 | 4.3% | 1.2% | ||
| Q1 25 | 4.8% | 1.0% | ||
| Q4 24 | 2.7% | 1.9% | ||
| Q3 24 | 3.3% | 1.5% | ||
| Q2 24 | 2.9% | 3.0% | ||
| Q1 24 | 5.5% | 3.3% |
现金转化率LWAYNATR
| Q4 25 | 0.11× | 2.41× | ||
| Q3 25 | 1.96× | 3.46× | ||
| Q2 25 | 0.92× | 0.81× | ||
| Q1 25 | -0.04× | 0.55× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.50× | 2.21× | ||
| Q2 24 | 1.73× | 0.97× | ||
| Q1 24 | 0.64× | 0.94× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LWAY
| Drinkable Kefirotherthan Pro Bugs | $47.8M | 86% |
| Cheese | $4.7M | 8% |
| Cream And Other | $1.7M | 3% |
| Other | $1.2M | 2% |
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
